As shown in Fig. 2e, these changes are linked to the activation of oncogenes involved in MM including SYK42–44, MET45,46, and SH3GL347 in NSD2-overexpressing cells (Fig. 2e). This evidence concerns the gene NSD2 and Miyoshi myopathy.